Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 10;13(8):1386.
doi: 10.3390/diagnostics13081386.

Osteoarthritis and Diabetes: Where Are We and Where Should We Go?

Affiliations
Review

Osteoarthritis and Diabetes: Where Are We and Where Should We Go?

Aqeel M Alenazi et al. Diagnostics (Basel). .

Abstract

Diabetes mellitus (DM) and osteoarthritis (OA) are chronic noncommunicable diseases that affect millions of people worldwide. OA and DM are prevalent worldwide and associated with chronic pain and disability. Evidence suggests that DM and OA coexist within the same population. The coexistence of DM in patients with OA has been linked to the development and progression of the disease. Furthermore, DM is associated with a greater degree of osteoarthritic pain. Numerous risk factors are common to both DM and OA. Age, sex, race, and metabolic diseases (e.g., obesity, hypertension, and dyslipidemia) have been identified as risk factors. These risk factors (demographics and metabolic disorder) are associated with DM or OA. Other possible factors may include sleep disorders and depression. Medications for metabolic syndromes might be related to the incidence and progression of OA, with conflicting results. Given the growing body of evidence indicating a relationship between DM and OA, it is vital to analyze, interpret, and integrate these findings. Therefore, the purpose of this review was to evaluate the evidence on the prevalence, relationship, pain, and risk factors of both DM and OA. The research was limited to knee, hip, and hand OA.

Keywords: diabetics; gait; high blood glucose; osteoarthritis; pace; pain intensity; symptoms.

PubMed Disclaimer

Conflict of interest statement

All authors declare they have no conflict of interest.

Similar articles

Cited by

References

    1. Cui A., Li H., Wang D., Zhong J., Chen Y., Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020;29–30:100587. doi: 10.1016/j.eclinm.2020.100587. - DOI - PMC - PubMed
    1. Gabriel S.E., Crowson C.S., Campion M.E., O’Fallon W.M. Direct medical costs unique to people with arthritis. J. Rheumatol. 1997;24:719–725. - PubMed
    1. Zhou T., Liu P., Dhruva S.S., Shah N.D., Ramachandran R., Berg K.M., Ross J.S. Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019. JAMA Intern. Med. 2022;182:185. - PMC - PubMed
    1. Litwic A., Edwards M.H., Dennison E.M., Cooper C. Epidemiology and burden of osteoarthritis. Br. Med. Bull. 2013;105:185–199. doi: 10.1093/bmb/lds038. - DOI - PMC - PubMed
    1. The Burden of Musculoskeletal Diseases in the United States (BMUS) [(accessed on 20 December 2018)]. Available online: http://www.boneandjointburden.or.

LinkOut - more resources